The San Antonio Breast Cancer Symposium^® recognizes that satellite symposia are arranged in conjunction with the scheduled Symposium dates as a convenience to the target audience in attendance.

The 2025 Satellite Educational Symposia application deadline has passed. The symposia will take place at the San Antonio Marriott Rivercenter. These are not official programs of the San Antonio Breast Cancer Symposium®. Satellite Educational Symposia are autonomous, CME-accredited events that are held as an adjunct to the San Antonio Breast Cancer Symposium (SABCS) and are supported by an organization other than the SABCS. Satellite Educational Symposia go through a rigorous approval process and are evaluated for their ability to provide educational content distinct from and/or that enhances the content provided by the official SABCS scientific program.

2025 Satellite Symposia Schedule

Monday, December 8 - 7:00 to 10:00 PM

Medical Crossfire®: From Frontline to Heavily Pretreated HR+/HER2- Metastatic Breast Cancer – Expert Perspectives on Optimizing the Expanding Treatment Armamentarium
- Physicians' Education Resource
Location: San Antonio Marriott Rivercenter Salons CDE
Event Supporter: AstraZeneca
 

Show Me the Data™: Personalizing First-Line and Maintenance Therapy in HER2+ Metastatic Breast Cancer to Extend Survival and Elevate Quality of Life 
- Physicians' Education Resource
Location: San Antonio Marriott Rivercenter Salons ABF
Event Supporter: Pfizer

Tuesday, December 9 - 7:00 to 10:00 PM

Dialing-Up the Precision in HR+, HER2- mBC With Biomarker-Guided Targeted Therapies and Next-Generation Endocrine Agents: Adapting to an Evolving Framework for Identifying Molecular Alterations, Personalizing Therapy Selection & Sequencing, and Addressing Endocrine Resistance
- Peer View Institute
Location: San Antonio Marriott Rivercenter Salons ABF
Event Supporters: AstraZeneca, Genentech, Lilly, and Stemline Therapeutics, Inc.
 

Medical Crossfire® Mastering the Nuances of Early-Stage HR+/HER2- Breast Cancer: Expert Perspectives on Applying Modern Treatment Paradigms
- Physicians' Education Resource
Location: San Antonio Marriott Rivercenter Salons CDE
Event Supporter: AstraZeneca
 

Cases from the Community: Investigators Discuss the Role of Antibody-Drug Conjugates in the Management of Triple-Negative and HR-Positive Metastatic Breast Cancer
- Research To Practice
Location: San Antonio Marriott Rivercenter Salons HIJLK
Event Supporter: Gilead Sciences Inc.

Extending Efficacy: New Approaches for Endocrine- Resistant HR+/HER2- Advanced Breast Cancer
- The Phillips Group
Location: San Antonio Marriott Rivercenter Salons GM
Event Supporter: Celcuity, Inc.

Wednesday, December 10 - 7:00 to 10:00 PM

Medical Crossfire® The Who, When, and How of TROP2-Targeting, ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer
- Physicians' Education Resource
Location: San Antonio Marriott Rivercenter Salons CDE
Event Supporters: AstraZeneca and Daiichi Sankyo, Inc.
 

Four Steps to Success With CDK4/6 Inhibition in Early Through Metastatic Breast Cancer: Practicalities of Stratification, Selection, Sequencing, and Specialty Management
- Peer View Institute
Location: San Antonio Marriott Rivercenter Salons ABF
Event Supporters: Novartis and Lilly

Cases from the Community: Investigators Discuss the Optimal Management of Patients with HER2-Positive Breast Cancer
- Research To Practice
Location: San Antonio Marriott Rivercenter Salons HIJKL
Event Supporters: AstraZeneca and Daiichi Sankyo Inc.

Thursday, December 11 - 7:00 to 9:30 PM

Forging New Paths Through the Breast Cancer Clinical Landscape: The Earlier Use of ADCs to Improve Patient Outcomes
- Peer View Institute
Location: San Antonio Marriott Rivercenter Salons ABF
Event Supporters: AstraZeneca and Daiichi Sankyo Inc.

Medical Crossfire™: Navigating the Expanding Arsenal of Endocrine Therapies for HR+/HER2- Metastatic Breast Cancer – How Can PROTAC ER Degradation Shift the Standard?
- Physicians' Education Resource
Location: San Antonio Marriott Rivercenter CDE
Event Supporter: Pfizer

Cases from the Community: Investigators Discuss the Optimal Role of Endocrine-Based Therapy in the Management of Breast Cancer
- Research To Practice
Location: San Antonio Marriott Rivercenter Salons HIJKL
Event Supporters: Genentech, a member of the Roche Group, Lilly and Stemline Therapeutics Inc.